Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease
- PMID: 11958863
- DOI: 10.1016/s0306-4522(01)00460-2
Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease
Abstract
Amyloid beta(1-42), a major component of amyloid plaques, binds with exceptionally high affinity to the alpha 7 nicotinic acetylcholine receptor and accumulates intracellularly in neurons of Alzheimer's disease brains. In this study, we investigated the possibility that this binding plays a key role in facilitating intraneuronal accumulation of amyloid beta(1-42). Consecutive section immunohistochemistry and digital imaging were used to reveal the spatial relationship between amyloid beta(1-42) and the alpha 7 receptor in affected neurons of Alzheimer's disease brains. Results showed that neurons containing substantial intracellular accumulations of amyloid beta(1-42) invariably express relatively high levels of the alpha 7 receptor. Furthermore, this receptor is highly co-localized with amyloid beta(1-42) within neurons of Alzheimer's disease brains. To experimentally test the possibility that the binding interaction between exogenous amyloid beta(1-42) and the alpha 7 receptor facilitates internalization and intracellular accumulation of amyloid beta(1-42) in Alzheimer's disease brains, we studied the fate of exogenous amyloid beta(1-42) and its interaction with the alpha 7 receptor in vitro using cultured, transfected neuroblastoma cells that express elevated levels of this receptor. Transfected cells exhibited rapid binding, internalization and accumulation of exogenous amyloid beta(1-42), but not amyloid beta(1-40). Furthermore, the rate and extent of amyloid beta(1-42) internalization was related directly to the alpha 7 receptor protein level, since (1) the rate of amyloid beta(1-42) accumulation was much lower in untransfected cells that express much lower levels of this receptor and (2) internalization was effectively blocked by alpha-bungarotoxin, an alpha 7 receptor antagonist. As in neurons of Alzheimer's disease brains, the alpha 7 receptor in transfected cells was precisely co-localized with amyloid beta(1-42) in prominent intracellular aggregates. Internalization of amyloid beta(1-42) in transfected cells was blocked by phenylarsine oxide, an inhibitor of endocytosis. We suggest that the intraneuronal accumulation of amyloid beta(1-42) in Alzheimer's disease brains occurs predominantly in neurons that express the alpha 7 receptor. In addition, internalization of amyloid beta(1-42) may be facilitated by the high-affinity binding of amyloid beta(1-42) to the alpha 7 receptor on neuronal cell surfaces, followed by endocytosis of the resulting complex. This provides a plausible explanation for the selective vulnerability of neurons expressing the alpha 7 receptor in Alzheimer's disease brains and for the fact that amyloid beta(1-42) is the dominant amyloid beta peptide species in intracellular accumulations and amyloid plaques.
Similar articles
-
Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.Curr Pharm Des. 2006;12(6):677-84. doi: 10.2174/138161206775474224. Curr Pharm Des. 2006. PMID: 16472157 Review.
-
Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains.Brain Res. 2003 May 9;971(2):197-209. doi: 10.1016/s0006-8993(03)02361-8. Brain Res. 2003. PMID: 12706236
-
Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease.Histopathology. 2001 Feb;38(2):120-34. doi: 10.1046/j.1365-2559.2001.01082.x. Histopathology. 2001. PMID: 11207825
-
beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology.J Biol Chem. 2000 Feb 25;275(8):5626-32. doi: 10.1074/jbc.275.8.5626. J Biol Chem. 2000. PMID: 10681545
-
α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?Curr Drug Targets. 2012 May;13(5):613-22. doi: 10.2174/138945012800398973. Curr Drug Targets. 2012. PMID: 22300028 Review.
Cited by
-
Cytotoxic Effect of Amyloid-β1-42 Oligomers on Endoplasmic Reticulum and Golgi Apparatus Arrangement in SH-SY5Y Neuroblastoma Cells.NeuroSci. 2024 May 7;5(2):141-157. doi: 10.3390/neurosci5020010. eCollection 2024 Jun. NeuroSci. 2024. PMID: 39483494 Free PMC article.
-
Induction of Non-Canonical Ferroptosis by Targeting Clusters Suppresses Glioblastoma.Pharmaceutics. 2024 Sep 13;16(9):1205. doi: 10.3390/pharmaceutics16091205. Pharmaceutics. 2024. PMID: 39339241 Free PMC article.
-
Quintessential Synergy: Concurrent Transient Administration of Integrated Stress Response Inhibitors and BACE1 and/or BACE2 Activators as the Optimal Therapeutic Strategy for Alzheimer's Disease.Int J Mol Sci. 2024 Sep 13;25(18):9913. doi: 10.3390/ijms25189913. Int J Mol Sci. 2024. PMID: 39337400 Free PMC article.
-
ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer's Disease: Origins, Progression, and Therapeutic Strategies.Int J Mol Sci. 2024 May 30;25(11):6036. doi: 10.3390/ijms25116036. Int J Mol Sci. 2024. PMID: 38892224 Free PMC article. Review.
-
On the Inadequacy of the Current Transgenic Animal Models of Alzheimer's Disease: The Path Forward.Int J Mol Sci. 2024 Mar 4;25(5):2981. doi: 10.3390/ijms25052981. Int J Mol Sci. 2024. PMID: 38474228 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
